DFWVX | VIHAX | DFWVX / VIHAX | |
Total Expense Ratio | 0.38 | 0.17 | 224% |
Annual Report Gross Expense Ratio | 0.57 | 0.17 | 335% |
Fund Existence | 15 years | 10 years | - |
Gain YTD | 30.846 | 25.712 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 389M | 13.4B | 3% |
Annual Yield % from dividends | 3.41 | 3.95 | 86% |
Returns for 1 year | 24.34 | 18.45 | 132% |
Returns for 3 years | 85.43 | 65.23 | 131% |
Returns for 5 years | 100.69 | 66.97 | 150% |
Returns for 10 years | 96.19 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBIOX | 23.27 | N/A | N/A |
Fidelity Select Biotechnology | |||
MSECX | 11.38 | N/A | N/A |
Morgan Stanley Inst International Eq C | |||
BDHAX | 8.95 | -0.03 | -0.33% |
BlackRock Dynamic High Income Inv A | |||
RLBEX | 38.89 | -0.14 | -0.36% |
American Funds American Balanced R4 | |||
ECEIX | 13.16 | -0.08 | -0.60% |
Lazard Emerging Markets Core Equity Inst |